Comparison of gene expression profiles in BALB/c 3T3 transformed foci exposed to tumor promoting agents

Toxicology in Vitro

Volumn 24, Issue 2, 2010, Pages 430-438

  Ao, Lin ^a,b   Liu, Jin yi ^a,b   Liu, Wen bin ^a,b   Gao, Li hong ^a,b   Hu, Ran ^a,b   Fang, Zhi jun ^c   Zhen, Zhi xiong ^c   Huang, Ming hui ^c   Yang, Meng su ^c   Cao, Jia ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

BALB c 3T3 cells; cDNA microarray; Cell transformation; Gene expression profile; Tumor promoter

Indexed keywords

BETA ACTIN; CADMIUM CHLORIDE; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 3; OKADAIC ACID; OSTEOPONTIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROCOLLAGEN; PROCOLLAGEN TYPE 1 ALPHA 2; PROTEIN LYSINE 6 OXIDASE; THIOREDOXIN 1; THROMBOSPONDIN 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ANCHORAGE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CHEMICAL CARCINOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 76549098490     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2009.10.006     Document Type: Article

References (59)

1. Aardema M.J., and MacGregor J.T. Toxicology and genetic toxicology in the new era of "toxicogenomics": impact of "-omics" technologies. Mutat. Res. 499 1 (2002) 13-25
2. Andrews, Z.B., Horvath, T., 2009. Uncoupling Protein 2 regulates lifespan in mice. Am. J. Physiol. Endocrinol. Metab. [Epub ahead of print].
3. Ao L., Liu J.Y., Gao L.H., Liu S.X., Yang M.S., Huang M.H., and Cao J. Differential expression of genes associated with cell proliferation and apoptosis induced by okadaic acid during the transformation process of BALB/c 3T3 cells. Toxicol. In Vitro 22 1 (2008) 116-127
4. Asada S., Sasaki K., Tanaka N., Takeda K., Hayashi M., and Umeda M. Detection of initiating as well as promoting activity of chemicals by a novel cell transformation assay using v-Ha-ras-transfected BALB/c 3T3 cells (Bhas 42 cells). Mutat. Res. 588 1 (2005) 7-21
5. Barrett J.C. Cell culture models of multistep carcinogenesis. IARC Sci. Publ. 58 (1985) 181-202
6. Berrier A.L., and Yamada K.M. Cell-matrix adhesion. J. Cell Physiol. 213 3 (2007) 565-573
7. Bertin G., and Averbeck D. Cadmium: cellular effects, modifications of biomolecules, modulation of DNA repair and genotoxic consequences (a review). Biochimie 88 11 (2006) 1549-1559
8. Boudreau R.T., and Hoskin D.W. The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system. Int. Immunopharmacol. 5 10 (2005) 1507-1518
9. Brzezinski P., and Gennis R.B. Cytochrome c oxidase: exciting progress and remaining mysteries. J. Bioenerg. Biomembr. 40 5 (2008) 521-531
10. Byoung Chan., Kim Man., and Bock Gu. Discrimination of toxic impacts of various chemicals using chemical-gene expression profiling of Escherichia coli DNA microarray. Process Biochem. 42 3 (2007) 392-400
11. Csiszar K. Lysyl oxidases: a novel multifunctional amine oxidase family. Prog. Nucleic Acid Res. Mol. Biol. 70 (2001) 1-32
12. DiGiovanni J. Multistage carcinogenesis in mouse skin. Pharmacol. Ther. 54 1 (1992) 63-128
13. Dounay A.B., and Forsyth C.J. Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor. Curr. Med. Chem. 9 22 (2002) 1939-1980
14. Dunkel V.C., Rogers C., Swierenga S.H., Brillinger R.L., Gilman J.P., and Nestmann E.R. Recommended protocols based on a survey of current practice in genotoxicity testing laboratories: III. Cell transformation in C3H/10T1/2 mouse embryo cell, BALB/c 3T3 mouse fibroblast and Syrian hamster embryo cell cultures. Mutat. Res. 246 2 (1991) 285-300
15. Eun J.W., Ryu S.Y., Noh J.H., Lee M.J., Jang J.J., Ryu J.C., Jung K.H., Kim J.K., Bae H.J., Xie H., Kim S.Y., Lee S.H., Park W.S., Yoo N.J., Lee J.Y., and Nam S.W. Discriminating the molecular basis of hepatotoxicity using the large-scale characteristic molecular signatures of toxicants by expression profiling analysis. Toxicology 249 2-3 (2008) 176-183
16. Fang M.Z., Kim D.Y., Lee H.W., and Cho M.H. Improvement of in vitro two-stage transformation assay and determination of the promotional effect of cadmium. Toxicol. In Vitro 15 3 (2001) 225-231
17. Fang M.Z., Mar W.C., and Cho M.H. Cadmium-induced alterations of connexin expression in the promotion stage of in vitro two-stage transformation. Toxicology 161 1-2 (2001) 117-127
18. Fang M.Z., Mar W., and Cho M.H. Cadmium affects genes involved in growth regulation during two-stage transformation of Balb/3T3 cells. Toxicology 177 2-3 (2002) 253-265
19. Fielden M.R., Brennan R., and Gollub J. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol. Sci. 99 1 (2007) 90-100
20. Fielden, M.R., Nie, A., McMillian, M., Elangbam, C.S., Trela, B.A., Yang, Y., Dunn, R.T. 2nd., Dragan, Y., Fransson-Stehen, R., Bogdanffy, M., Adams, S.P., Foster, W.R., Chen, S.J., Rossi, P., Kasper, P., Jacobson-Kram, D., Tatsuoka, K.S., Wier, P.J., Gollub, J., Halbert, D.N., Roter, A., Young, J.K., Sina, J.F., Marlowe, J., Martus, H.J., Aubrecht, J., Olaharski, A.J., Roome, N., Nioi, P., Pardo, I., Snyder, R., Perry, R., Lord, P., Mattes, W., Car, B.D., Predictive Safety Testing Consortium; Carcinogenicity Working Group. 2008. Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. Toxicol. Sci. 103(1), 28-34.
21. Fujiki H., Suganuma M., Okabe S., Sueoka E., Suga K., Imai K., and Nakachi K. A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (-)-epigallocatechin gallate and green tea - a review. Cancer Detect Prev. 24 1 (2000) 91-99
22. Gibbs P.E., and Maines M.D. Biliverdin inhibits activation of NF-kappaB: reversal of inhibition by human biliverdin reductase. Int. J. Cancer 121 11 (2007) 2567-2574
23. Gills J.J., Jeffery E.H., Matusheski N.V., Moon R.C., Lantvit D.D., and Pezzuto J.M. Sulforaphane prevents mouse skin tumorigenesis during the stage of promotion. Cancer Lett. 236 1 (2006) 72-79
24. Gottschalg E., Moore N.E., Ryan A.K., Travis L.C., Waller R.C., Pratt S., Atmaca M., Kind C.N., and Fry J.R. Phenotypic anchoring of arsenic and cadmium toxicity in three hepatic-related cell systems reveals compound- and cell-specific selective up-regulation of stress protein expression: implications for fingerprint profiling of cytotoxicity. Chem. Biol. Interact. 161 3 (2006) 251-261
25. Hegde P., Qi R., Abernathy K., Gay C., Dharap S., Gaspard R., Hughes J.E., Snesrud E., Lee N., and Quackenbush J. A concise guide to cDNA microarray analysis. Biotechniques 29 548-550 (2000) 552-554 556 passim
26. Iacovoni J.S., Cohen S.B., Berg T., and Vogt P.K. v-Jun targets showing an expression pattern that correlates with the transformed cellular phenotype. Oncogene 23 33 (2004) 5703-5706
27. IARC/NCI/EPA Working Group, 1985. Cellular and molecular mechanism of cell transformation and standardization of transformation assays of established cell lines for the prediction of carcinogenic chemicals: overview and recommended protocols. Cancer Res. 45, 2395-2399.
28. Ikuta S., Edamatsu H., Li M., Hu L., and Kataoka T. Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester. Cancer Res. 68 1 (2008) 64-72
29. Isani G., Andreani G., Cocchioni F., Fedeli D., Carpené E., and Falcioni G. Cadmium accumulation and biochemical responses in Sparus aurata following sub-lethal Cd exposure. Ecotoxicol. Environ. Saf. 72 1 (2009) 224-230
30. Kawata K., Shimazaki R., and Okabe S. Comparison of gene expression profiles in HepG2 cells exposed to arsenic, cadmium, nickel, and three model carcinogens for investigating the mechanisms of metal carcinogenesis. Environ. Mol. Mutagen 50 1 (2009) 46-59
31. Keshava C., Keshava N., Zhou G., Whong W.Z., and Ong T.M. Genomic instability in silica- and cadmium chloride-transformed BALB/c-3T3 and tumor cell lines by random amplified polymorphic DNA analysis. Mutat. Res. 425 1 (1999) 117-123
32. King T.J., and Bertram J.S. Connexins as targets for cancer chemoprevention and chemotherapy. Biochim. Biophys. Acta 1719 1-2 (2005) 146-160
33. Koizumi S., and Yamada H. DNA microarray analysis of altered gene expression in cadmium-exposed human cells. J. Occup. Health 45 6 (2003) 331-334
34. Kuramoto T., Morimura K., Yamashita S., Okochi E., Watanabe N., Ohta T., Ohki M., Fukushima S., Sugimura T., and Ushijima T. Etiology-specific gene expression profiles in rat mammary carcinomas. Cancer Res. 62 (2002) 3592-3597
35. Lord P.G. Progress in applying genomics in drug development. Toxicol. Lett. 149 1-3 (2004) 371-375
36. Messner D.J., Romeo C., Boynton A., and Rossie S. Inhibition of PP2A, but not PP5, mediates p53 activation by low levels of okadaic acid in rat liver epithelial cells. J. Cell Biochem. 99 1 (2006) 241-255
37. Nakajima M., Shimada S., Nagai M., Mizuhashi F., Sugiyama C., Masuda S., Hayashi M., and Kinae N. 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone [MX] shows initiating and promoting activities in a two-stage BALB/c 3T3 cell transformation assay. Mutagenesis 20 5 (2005) 375-379
38. Nebert D.W., and Vasiliou V. Analysis of the glutathione S-transferase (GST) gene family. Hum. Genomics 1 6 (2004) 460-464
39. Nie A.Y., McMillian M., Parker J.B., Leone A., Bryant S., Yieh L., Bittner A., Nelson J., Carmen A., Wan J., and Lord P.G. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Mol. Carcinog. 45 12 (2006) 914-933
40. Ogbi M., and Johnson J.A. Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning. Biochem. J. 393 Pt 1 (2006) 191-199
41. Payne S.L., Hendrix M.J., and Kirschmann D.A. Paradoxical roles for lysyl oxidases in cancer - a prospect. J. Cell Biochem. 101 6 (2007) 1338-1354
42. Plant N. Can systems toxicology identify common biomarkers of non-genotoxic carcinogenesis?. Toxicology 254 3 (2008) 164-169
43. Postema M.H., Piper J.L., Betts R.L., Valeriote F.A., and Pietraszkewicz H. RCM-based synthesis of a variety of beta-C-glycosides and their in vitro anti-solid tumor activity. J. Org. Chem. 70 3 (2005) 829-836
44. Rahman S., Bhatia K., Khan A.Q., Kaur M., Ahmad F., Rashid H., Athar M., Islam F., and Raisuddin S. Topically applied vitamin E prevents massive cutaneous inflammatory and oxidative stress responses induced by double application of 12-O-tetradecanoylphorbol-13-acetate (TPA) in mice. Chem. Biol. Interact. 172 3 (2008) 195-205
45. Rivenbark A.G., and Coleman W.B. Dissecting the molecular mechanisms of cancer through bioinformatics-based experimental approaches. J. Cell Biochem. 101 5 (2007) 1074-1086
46. Sakai A., Kikuchi Y., Muroi M., Masui T., Furihata C., Uchida E., Takatori K., and Tanamoto K. Overexpression of NP95 mRNA by tumor promoters in the promotion phase of a two-stage BALB/3T3 cell transformation assay. Biol. Pharm. Bull. 26 3 (2003) 347-351
47. Shan L., He M., Yu M., Qiu C., Lee N.H., Liu E.T., and Snyderwine E.G. cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 23 10 (2002) 1561-1568
48. Shan L., Yu M., and Snyderwine E.G. Gene expression profiling of chemically induced rat mammary gland cancer. Carcinogenesis 26 2 (2005) 503-509
49. Shan L., Yu M., and Snyderwine E.G. Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas. Toxicol. Pathol. 33 7 (2005) 768-775
50. Shin A.H., Kil I.S., Yang E.S., Huh T.L., Yang C.H., and Park J.W. Regulation of high glucose-induced apoptosis by mitochondrial NADP+dependent isocitrate dehydrogenase. Biochem. Biophys. Res. Commun. 325 1 (2004) 32-38
51. Stetler-Stevenson W.G. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci. Signal. 1 27 (2008) re6
52. Taji S., Yamada T., Wada S., Tokuda H., Sakuma K., and Tanaka R. Lanostane-type triterpenoids from the sclerotia of Inonotus obliquus possessing anti-tumor promoting activity. Eur. J. Med. Chem. 43 11 (2008) 2373-2379
53. Trosko J.E. Commentary: is the concept of "tumor promotion" a useful paradigm?. Mol. Carcinog. 30 3 (2001) 131-137
54. Trosko J.E., Chang C.C., Upham B.L., and Tai M.H. The role of human adult stem cells and cell-cell communication in cancer chemoprevention and chemotherapy strategies. Mutat. Res. 591 1-2 (2005) 187-197
55. Tsuchiya T., and Umeda M. Improvement in the efficiency of the in vitro transformation assay method using BALB/3T3 A31-1-1 cells. Carcinogenesis 16 8 (1995) 1887-1894
56. Túnez I., Collado J.A., Medina F.J., Muñoz M.C., Gordillo R., Sampedro C., Moyano M.J., Feijóo M., Muntané J., and Montilla P. Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells. Pharmacol. Res. 54 3 (2006) 241-246
57. Uehara T., Hirode M., Ono A., Kiyosawa N., Omura K., Shimizu T., Mizukawa Y., Miyagishima T., Nagao T., and Urushidani T. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. Toxicology 250 1 (2008) 15-26
58. Wei Q., Jiang H., Matthews C.P., and Colburn N.H. Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc. Natl. Acad. Sci. USA 105 50 (2008) 19738-19743
59. Yang S., Misner B., Chiu R., and Meyskens Jr. F.L. Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells. Mol. Carcinog. 47 7 (2008) 485-491